160 related articles for article (PubMed ID: 29785284)
1. Vinorelbine-induced regression of a choroidal metastasis from primary breast carcinoma.
Arya M; Duker JS
Int J Retina Vitreous; 2018; 4():17. PubMed ID: 29785284
[TBL] [Abstract][Full Text] [Related]
2. Regression of choroidal metastasis from breast carcinoma with palbociclib.
Parakh S; Das S; Maheshwari S; Gupta V; Luthra G; Luthra S
Int J Retina Vitreous; 2022 Aug; 8(1):54. PubMed ID: 35962417
[TBL] [Abstract][Full Text] [Related]
3. NEAR-INFRARED AUTOFLUORESCENCE IN BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION ASSOCIATED WITH ESOPHAGEAL CARCINOMA AND CHOROIDAL METASTASIS.
Golshahi A; Bornfeld N; Weinitz S; Kellner U
Retin Cases Brief Rep; 2016; 10(3):254-8. PubMed ID: 26807495
[TBL] [Abstract][Full Text] [Related]
4. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
Goa KL; Faulds D
Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
[TBL] [Abstract][Full Text] [Related]
5. Future directions for vinorelbine (Navelbine).
Hortobagyi GN
Semin Oncol; 1995 Apr; 22(2 Suppl 5):80-6; discussion 86-7. PubMed ID: 7740338
[TBL] [Abstract][Full Text] [Related]
6. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
Sui M; Jiang D; Hinsch C; Fan W
Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
[TBL] [Abstract][Full Text] [Related]
7. Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study.
Steger GG; Dominguez A; Dobrovolskaya N; Giotta F; Tubiana-Mathieu N; Pecherstorfer M; Ardizzoia A; Blasinska-Morawiec M; Espinosa E; Villanova G
Clin Breast Cancer; 2018 Feb; 18(1):e41-e47. PubMed ID: 28666812
[TBL] [Abstract][Full Text] [Related]
8. Unusual Case of Papillary Thyroid Carcinoma with Choroidal Metastasis.
Makhija C; Su YB; Goldner W
Thyroid; 2015 Jul; 25(7):860-4. PubMed ID: 25872533
[TBL] [Abstract][Full Text] [Related]
9. Systemic chemotherapy and tamoxifen induced regression of choroidal metastasis from a breast carcinoma in a male.
Shome D; Jayadev C; Gadgil D; Natarajan S; Jain V
Indian J Ophthalmol; 2007; 55(6):475-7. PubMed ID: 17951913
[TBL] [Abstract][Full Text] [Related]
10. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
11. Male Breast Carcinoma Metastatic to the Choroid: A Case Report and Opinions of Management.
Fu W; Zheng S; Zhou J; Lu K; Lu Y; Guo G
Cancer Manag Res; 2022; 14():525-534. PubMed ID: 35173486
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous regression of choroidal metastasis from renal cell carcinoma.
Rodriguez SM; Boldt HC; Sullivan HR; Rieth JM; Zakharia Y; Binkley EM
Am J Ophthalmol Case Rep; 2023 Dec; 32():101945. PubMed ID: 37886109
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor-positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial).
Aapro M; Ruiz-Borrego M; Hegg R; Kukielka-Budny B; Morales S; Cinieri S; Freitas-Junior R; Garcia-Estevez L; Szombara E; Borges GS; Passalacqua R; Hervieu H; Groc M; Villanova G
Breast; 2019 Jun; 45():7-14. PubMed ID: 30802822
[TBL] [Abstract][Full Text] [Related]
14. Vinorelbine-related tetraplegia due to severe peripheral neuropathy.
Bayram E; Demir T; Kaya O; Paydas S
J Oncol Pharm Pract; 2023 Jul; ():10781552231191469. PubMed ID: 37499222
[TBL] [Abstract][Full Text] [Related]
15. Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.
Harbeck N; Huang CS; Hurvitz S; Yeh DC; Shao Z; Im SA; Jung KH; Shen K; Ro J; Jassem J; Zhang Q; Im YH; Wojtukiewicz M; Sun Q; Chen SC; Goeldner RG; Uttenreuther-Fischer M; Xu B; Piccart-Gebhart M;
Lancet Oncol; 2016 Mar; 17(3):357-366. PubMed ID: 26822398
[TBL] [Abstract][Full Text] [Related]
16. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
[TBL] [Abstract][Full Text] [Related]
17. Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.
Zelek L; Barthier S; Riofrio M; Fizazi K; Rixe O; Delord JP; Le Cesne A; Spielmann M
Cancer; 2001 Nov; 92(9):2267-72. PubMed ID: 11745280
[TBL] [Abstract][Full Text] [Related]
18. Dramatic response of choroidal metastases from breast cancer to a combination of trastuzumab and vinorelbine.
Wong ZW; Phillips SJ; Ellis MJ
Breast J; 2004; 10(1):54-6. PubMed ID: 14717761
[TBL] [Abstract][Full Text] [Related]
19. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
Kanazawa J; Morimoto M; Ohmori K
Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.
Menendez JA; Colomer R; Lupu R
Oncol Rep; 2004 Aug; 12(2):411-22. PubMed ID: 15254710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
